# Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)

> **NCT00746941** · PHASE1,PHASE2 · TERMINATED · sponsor: **Biogen** · enrollment: 37 (actual)

## Conditions studied

- Progressive Multifocal Leukoencephalopathy

## Interventions

- **DRUG:** mefloquine

## Key facts

- **NCT ID:** NCT00746941
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Primary endpoint not achieved
- **Last updated:** 2014-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746941, "Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00746941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*